AAAAAA

   
Results: 1-8 |
Results: 8
The pharmacokinetics and pharmacodynamics of irbesartan in heart failure
Authors: Kostis, JB Vachharajani, NN Hadjilambris, OW Kollia, GD Palmisano, M Marino, MR
Citation: Jb. Kostis et al., The pharmacokinetics and pharmacodynamics of irbesartan in heart failure, J CLIN PHAR, 41(9), 2001, pp. 935-942
Pharmacodynamics and pharmacokinetics of omapatrilat in heart failure
Authors: Kostis, JB Klapholz, M Delaney, C Vesterqvist, O Cohen, M Manning, JA Jemal, M Kollia, GD Liao, WC
Citation: Jb. Kostis et al., Pharmacodynamics and pharmacokinetics of omapatrilat in heart failure, J CLIN PHAR, 41(12), 2001, pp. 1280-1290
A dose-escalation study of the safety, tolerability, and pharmacokinetics of intravenous gatifloxacin in healthy adult men
Authors: Gajjar, DA LaCreta, FP Uderman, HD Kollia, GD Duncan, G Birkhofer, MJ Grasela, DM
Citation: Da. Gajjar et al., A dose-escalation study of the safety, tolerability, and pharmacokinetics of intravenous gatifloxacin in healthy adult men, PHARMACOTHE, 20(6), 2000, pp. 49S-58S
Interchangeability of 400-mg intravenous and oral gatifloxacin in healthy adults
Authors: LaCreta, FP Kaul, S Kollia, GD Duncan, G Randall, DM Grasela, DM
Citation: Fp. Lacreta et al., Interchangeability of 400-mg intravenous and oral gatifloxacin in healthy adults, PHARMACOTHE, 20(6), 2000, pp. 59S-66S
Age and gender effects on the pharmacokinetics of gatifloxacin
Authors: LaCreta, FP Kollia, GD Duncan, G Behr, D Grasela, DM
Citation: Fp. Lacreta et al., Age and gender effects on the pharmacokinetics of gatifloxacin, PHARMACOTHE, 20(6), 2000, pp. 67S-75S
Effect of multiple-dose gatifloxacin or ciprofloxacin on glucose homeostasis and insulin production in patients with noninsulin-dependent diabetes mellitus maintained with diet and exercise
Authors: Gajjar, DA LaCreta, FP Kollia, GD Stolz, RR Berger, S Smith, WB Swingle, M Grasela, DM
Citation: Da. Gajjar et al., Effect of multiple-dose gatifloxacin or ciprofloxacin on glucose homeostasis and insulin production in patients with noninsulin-dependent diabetes mellitus maintained with diet and exercise, PHARMACOTHE, 20(6), 2000, pp. 76S-86S
Safety and pharmacokinetics of a single oral dose of gatifloxacin in patients with moderate to severe hepatic impairment
Authors: Grasela, DM Christofalo, B Kollia, GD Duncan, G Noveck, R Manning, JA LaCreta, FP
Citation: Dm. Grasela et al., Safety and pharmacokinetics of a single oral dose of gatifloxacin in patients with moderate to severe hepatic impairment, PHARMACOTHE, 20(6), 2000, pp. 87S-94S
Open-label, nonrandomized study of the effects of gatifloxacin on the pharmacokinetics of midazolam in healthy male volunteers
Authors: Grasela, DM LaCreta, FP Kollia, GD Randall, DM Uderman, HD
Citation: Dm. Grasela et al., Open-label, nonrandomized study of the effects of gatifloxacin on the pharmacokinetics of midazolam in healthy male volunteers, PHARMACOTHE, 20(3), 2000, pp. 330-335
Risultati: 1-8 |